Pharmaceuticals

Global Small Molecule Targeted Cancer Therapy Market (Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

  • ALL22837
  • 0 Pages
  • November 1999
  • Pharmaceuticals

Small Molecule Targeted Cancer Therapy is the medication that blocks the cancerous cells growth by destroying the targeted molecules that result in the growth of tumor and carcinogenesis. Conventional chemotherapies and cytotoxin medications destroy the division of cancerous cells by inhibiting the process of cell division. Targeted Cancer therapy is considered to be more effective than the conventional methods and prevent normal cells from harmful radiations. Small Molecule Targeted Cancer Therapy has broad spectrum of application in multiple myeloma, melanoma, prostate cancer, lymphoma, breast cancer, and all other cancers.

Small Molecule Targeted Cancer Therapy has a targeted approach and minimal after side- effects; this results into increased rate of adoption of the therapy by the end users. This is the major factor that is driving the growth of the market. Moreover, increase in the rate of cancer incidences is also contributing to the growth of the market. The substantial hurdle for the growth of the market is the rate of the approved chemical drugs that is declining every year due to stringent regulations. In addition, low awareness among end-users and high operational cost are also hampering the growth of the market. Drugs that are losing their patents such as Norvartis’s Glivec are unlocking the door of opportunity for the manufacturers of the Small Molecule Targeted Cancer Therapy.

Small Molecule Targeted Cancer Therapy Type Market Analysis

Small Molecule Targeted Cancer Therapy type market is segmented into monoclonal antibodies, small molecules and small molecule drug conjugates. Monoclonal antibodies can be further segmented into fully human antibody (with an immune system target), chimeric monoclonal antibody (with a tumor target) and humanized monoclonal antibody (with a circulatory system target). Small Molecules can also be further segmented into small molecule cyclin-dependent kinase inhibitor, small molecule proteasome inhibitor and small molecule tyrosine kinase inhibitor. Small Molecules segment is the largest revenue generating segment due to its kinase inhibitor that can provide relatively more protection to the normal cells. It can efficiently destroy the selected target cells and prevent the growth of the tumor.

Small Molecule Targeted Cancer Therapy Geography Market Analysis

Geographically, Market is segmented into North America, Europe, Asia Pacific and RoW. North America is the largest revenue generating segment due to relative rise in the cancer cases.

Competitive Landscape

The key strategies adopted by the companies to expand in the Small Molecule Targeted Cancer Therapy market are product launches, mergers & acquisitions and agreements & collaborations. These strategies would provide efficient products and yield strong performing products that support the market regulations and finally, exhibit better customer satisfaction. The companies profiled in this report are OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Bayer HealthCare AG, and Abbott Laboratories.

High Level Analysis

The report analyzes various macro environments of the Small Molecule Targeted Cancer Therapy market using porter’s analysis. According to porter’s analysis, the bargaining power of the supplier is high due to high cost of switching. The bargaining power of buyer is low due to the specialized products of Small Molecule Targeted Cancer Therapy market and threat of substitute is low due to unavailability of alternate products.

Key Benefits

  • The study helps to analyze the Small Molecule Targeted Cancer Therapy market trends to provide excess intelligence into the entire market segment and thus, helps the market players to make strategic decisions
  • To study the various factors that are enhancing and restraining the development of the market that would help the stakeholders in understanding the market in detail
  • To identify competitive strategies adopted by the top players due to certain government regulations and thus, assist the stakeholders in taking actionable decisions
  • Porter’s five forces model helps to understand the scope of bargaining power of buyers and suppliers and threat of the new entrants
  • The analysis focuses on the wide variety of opportunities for the growth and expansion of the market

Key Market Segment

Small Molecule Targeted Cancer Therapy market Analysis is segmented on the basis of Type and geographies.

Market by Type

  • Monoclonal Antibodies
    • Fully Human Antibody
    • Chimeric Monoclonal Antibody
    • Humanized Monoclonal Antibody
  • Small Molecules
    • Small Molecule Cyclin-dependent Kinase Inhibitor
    • Small Molecule Proteasome Inhibitor
    • Small Molecule Tyrosine Kinase Inhibitor
  • Small Molecule Drug Conjugates

Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • RoW
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>